Mibetin

Betamethasone dipropionate, the active ingredient in Mibetin, is a combination corticosteroid and aminoglycoside antibiotic presented as a topical formulation for skin use. It treats inflammatory dermatoses and bacterial skin infections in adults and children when prescribed by a healthcare professional.

GNH USA supplies Mibetin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mibetin combines a corticosteroid and an aminoglycoside to address inflammatory and bacterial skin conditions. It is indicated for: - Eczema: reduces inflammation and limits secondary bacterial infection, improving itching and redness. - Contact dermatitis: alleviates swelling and erythema while controlling microbial colonisation. - Infected dermatitis: provides anti‑inflammatory action and bactericidal effect to clear infection and promote healing.

Mibetin may cause local and systemic reactions typical of topical corticosteroids and aminoglycosides.

Common Side Effects: - Burning or stinging at the application site. - Mild skin irritation or itching. - Dryness or peeling of the treated area. - Temporary discoloration of the skin. - Folliculitis.

Serious or Rare Side Effects: - Contact dermatitis or allergic reaction with swelling and rash. - Secondary skin infection due to over‑growth of resistant organisms. - Systemic absorption leading to adrenal suppression (rare with extensive use). - Ototoxicity or nephrotoxicity (extremely rare with topical use). - Severe hypersensitivity reactions such as Stevens‑Johnson syndrome.

Before using Mibetin, consider the following safety measures: - Pregnancy: consult a healthcare provider; safety data are limited. - Breastfeeding: discuss potential risks with a clinician. - Children: use only under medical supervision; monitor for growth‑related effects. - Long‑term use: avoid prolonged application on large body areas to reduce systemic exposure. - Occlusive dressings: do not cover treated skin unless directed by a physician. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Mibetin can interact with other medications applied to the skin or systemic agents.

Major Interactions (Avoid): - Systemic corticosteroids: may increase risk of adrenal suppression. - Nephrotoxic or ototoxic drugs (e.g., aminoglycoside antibiotics): additive toxicity is possible.

Moderate Interactions (Monitor Closely): - Topical immunosuppressants (e.g., tacrolimus): may enhance local immunosuppression. - Antifungal agents: potential for reduced efficacy of the steroid component. - Skin barrier‑altering products (e.g., keratolytics): may increase systemic absorption.